Anti-HIV drug update.

There continues to be progress in the development of a number of new anti-HIV drugs. Additional research has focused on optimizing the use of protease inhibitors and non-nucleoside reverse transcriptase inhibitors (NNRTIs). This has resulted in studies of dual protease inhibitor combinations, protease inhibitor and NNRTI combinations and now dual NNRTI combinations.